HRCM
AKRO

Hood River Capital Management’s Akero Therapeutics AKRO Stock Holding History

Hood River Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-178,549
Closed -$8.48M – 176
2025
Q3 		$8.48M Buy
+178,549
New +$8.65M 0.1% 127

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hood River Capital Management's AKRO Position: Q4 2025 in Review

Hood River Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 178,549 shares — an estimated $8.48M sold.

Hood River Capital Management first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $8.48M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Hood River Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Hood River Capital Management sold 178,549 Akero Therapeutics shares in Q4 2025, an estimated $8.48M.
  • Hood River Capital Management first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • Hood River Capital Management's Akero Therapeutics position peaked at $8.48M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Hood River Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.